Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients who do not respond to the "usual" dose: why Terry fell off the dose-response curve.

Journal of psychiatric practice - 1 Nov 2009

Preskorn Sheldon H

Abstract excerpt

Clinical trials are aimed at determining what happens in the "usual" patient; however, clinicians are interested in what happens in their patients even if they are not usual. The usual dose-response relationship is determined as part of the drug development process required for approval of a new...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dose-Response Relationship, Drug
Share to Genetic Variation
Share to Psychotropic Drugs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 19934721
DOI: 10.1097/01.pra.0000364288.01328.44

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19934721-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients who do not respond to the "usual" dose: why Terry fell off the dose-response curve.PMID 19934721Read ↗

When good drugs go bad.Semantic proximity Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

Fitting the drug to the patient.Semantic proximity Read ↗

Drug resistance and treatment of experienced patients.Semantic proximity Read ↗

Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.Semantic proximity Read ↗

Drug resistance and the treatment of experienced patients.Semantic proximity Read ↗

Benefits and risks of medications: challenges for the 21st century.Semantic proximity Read ↗

Dosing Time MattersSemantic proximity Read ↗

Resistance: Crizotinib makes a comeback.Semantic proximity Read ↗

Pharmacogenomics: why standard codeine doses can have serious toxicities or no therapeutic effect.Semantic proximity Read ↗

DRUG REPURPOSING-Overcoming the translational hurdles to clinical use.Semantic proximity Read ↗

The Cost and Value of Anti-Epidermal Growth Factor Receptor Therapies: Let's Not Be Rash.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.